PATENT CLAIM ANALYSIS

Application Number: 15882399
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "493000"]

Abstract:
The invention provides compositions including epinephrine nanoparticles and methods for therapeutic use of the compositions in the treatment of conditions responsive to epinephrine such as a cardiac event or an allergic reaction, particularly anaphylaxis. The epinephrine nanoparticles can be incorporated into orally-disintegrating and fast-disintegrating tablet pharmaceutical formulations and can significantly increase the sublingual bioavailability of epinephrine, and thereby reduce the epinephrine dose required. Additionally, the invention provides methods for fabrication of stabilized epinephrine nanoparticles for use in the described compositions.

Claim (Index 14):
A method for treating a condition responsive to epinephrine in a subject in need thereof, comprising administering the epinephrine nanoparticles of  claim 1  to the subject, wherein the condition is a cardiac event or an allergic reaction.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 86.0
- Lexical Diversity: 1.62264
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15266843', '15262961', '15288745', '15358743', '13929100']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6718819901397666
- 35 USC 102 Novelty (BERT): 0.6444854064254761
- Combined Prediction Score: 0.6691423317683375
- Mean Citation Score: 397.70013
- Max Citation Score: 634.12286
- Similarity Product: 559.3204574421717

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test